Hbm Alpha Therapeutics Raises Seed Round To Advance Next-Gen Therapies For Endocrine Disorders
Round Type
Seed
Description
HBM Alpha Therapeutics (HBMAT), Inc., an innovative biotechnology company incubated by Harbour BioMed (HKEX: 02142), announced that it completed seed financing to advance its leading programs, novel antibody therapies to treat congenital adrenal hyperplasia (CAH) and polycystic ovary syndrome (PCOS), with the lead candidate currently in IND-enabling stage.
Quick answer
HBM Alpha Therapeutics raised an undisclosed amount in a Seed round, dated January 26, 2023. HBM Alpha Therapeutics is based in Cambridge, Maryland, United States.
- How much did HBM Alpha Therapeutics raise?
- HBM Alpha Therapeutics raised an undisclosed amount in a Seed round on January 26, 2023.
- What does HBM Alpha Therapeutics do?
- HBM Alpha Therapeutics is a company presently developing antibody therapeutics aimed at the rare genetic disease congenital adrenal hyperplasia (CAH) and polycystic ovary syndrome (PCOS).
- Where is HBM Alpha Therapeutics based and how big is it?
- HBM Alpha Therapeutics is based in Cambridge, Maryland, United States.
Source: Fundz verified event record.
Who else raised in Medical and Therapeutics around the same time
Companies in the same sectors as HBM Alpha Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Transcend Therapeutics raised an undisclosed amount (Series A) on February 23, 2023.
- Current Surgical raised $3.2M (Seed) on February 21, 2023.
- Grey Wolf Therapeutics raised $49M (Funding Round) on January 27, 2023.
- Actimed Therapeutics raised $12M (Seed) on January 4, 2023.
- Virax Biolabs raised $4M on March 10, 2023.
- QurAlis raised $88M (Series B) on March 9, 2023.
Who to call at HBM Alpha Therapeutics, and when
A new round usually means HBM Alpha Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day HBM Alpha Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at HBM Alpha Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at HBM Alpha Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment HBM Alpha Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
HBM Alpha Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.